References
- Ammar Asban, Anish J. Patel, Sushanth Reddy, Thomas Wang, Courtney J. Balentine and Herbert Chen. Chapter 68: Cqncer of the Endocrine System. In Niederhuber JE, Armitage JO et al. Abeloff’s Clinical Oncology. 6th Edition. Elsevier. 2020.
- Antonio M. Lerario, Dipika R. Mohan, Roy Lirov, Tobias Else, and Gary D. Hammer. Chapter 83: Adrenal Tumors. In: DeVita VTJ, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer Principles and Practice of Oncology. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2019.
- Creemers SG, Hofland LJ, Korpershoek E, Franssen GJ, van Kemenade FJ, de Herder WW et al. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma. Endocr Relat Cancer. 2016; 23:R43-69.
- Tizianel I, Caccese M, Torresan F, Lombardi G, Evangelista L, Crimì F et al. The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation. Cancers (Basel). 2022; 14:3904.
- Shetty I, Fuller S, Raygada M, Merino MJ, Thomas BJ, Widemann BC et al. Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma. Endocrinol Diabetes Metab Case Rep. 2020:19-0147.
- Souteiro P, Donato S, Costa C, Pereira CA, Simões-Pereira J, Oliveira J et al. Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study. Hormones (Athens). 2020;19:197-203.
- Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C et al. Weiss System Revisited: A Clinicopathologic and Immunohistochemical Study of 49 Adrenocortical Tumors. The American Journal of Surgical Pathology. 2022; 26: 1612-1619.
- Papotti M, Libè R, Duregon E, Volante M, Bertherat J, Tissier F. The Weiss score and beyond--histopathology for adrenocortical carcinoma. Horm Cancer. 2011; 2:333-40.
- Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM et al. Adrenocortical carcinoma. Endocr Rev. 2014; 35:282-326.
- Shariq OA, McKenzie TJ. Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment. Ther Adv Chronic Dis. 2021;12:20406223211033103.
- Mizdrak M, Tičinović Kurir T, Božić J. The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives. Biomedicines. 2021; 9:174.
- Petr EJ, Else T. Adrenocortical carcinoma (ACC): When and why should we consider germline testing? Presse Med. 2018; 47:e119-e125.
- Ruggiero E, Tizianel I, Caccese M, Lombardi G, Pambuku A, Zagonel V et al. Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care. Cancers (Basel). 2022;14:5901.
- Else T, Williams AR, Sabolch A, Jolly S, Miller BS, Hammer GD. Adjuvant Therapies and Patient and Tumor Characteristics Associated With Survival of Adult Patients With Adrenocortical Carcinoma, The Journal of Clinical Endocrinology & Metabolism, Volume 99, Issue 2. 2014: 455–461.